Ellington Management Group’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-18,600
| Closed | -$218K | – | 206 |
|
|
2020
Q1 | $218K | Buy |
+18,600
| New | +$218K | 0.05% | 399 |
|
|
2018
Q3 | – | Sell |
-9,200
| Closed | -$357K | – | 573 |
|
|
2018
Q2 | $357K | Buy |
9,200
+400
| +5% | +$15.5K | 0.03% | 234 |
|
|
2018
Q1 | $243K | Sell |
8,800
-2,000
| -19% | -$55.2K | 0.02% | 651 |
|
|
2017
Q4 | $195K | Buy |
+10,800
| New | +$195K | 0.03% | 484 |
|
|
2017
Q2 | – | Sell |
-10,400
| Closed | -$156K | – | 743 |
|
|
2017
Q1 | $156K | Buy |
+10,400
| New | +$156K | 0.01% | 607 |
|
|
2015
Q3 | – | Sell |
-8,856
| Closed | -$276K | – | 785 |
|
|
2015
Q2 | $276K | Buy |
+8,856
| New | +$276K | 0.07% | 467 |
|